{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:53Z","timestamp":1758361373471,"version":"3.44.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder, with heartburn as its hallmark symptom. While proton pump inhibitors (PPIs) remain the cornerstone of GERD management, a significant subset of patients exhibits refractory symptoms, necessitating further diagnostic evaluation. The utility and predictors of clinically significant findings (CSFs) during gastroscopy in PPI-refractory patients remain underexplored. We aimed to evaluate the diagnostic yield of gastroscopy in patients with PPI-refractory heartburn and identify predictors of CSFs. This retrospective multi-center cohort study included 6488 patients undergoing gastroscopy at two teaching hospitals between 2012 and 2022. Patients were stratified into three groups based on treatment status: PPI therapy, H2 receptor antagonists (H2RAs), and no pharmacological treatment. Demographic, clinical, and procedural data were extracted from electronic medical records. CSFs were defined as moderate-to-severe esophagitis, esophageal stricture, histologically confirmed Barrett\u2019s esophagus, upper GI malignancies, or gastric and duodenal ulcers. Diagnostic yield and the number needed to investigate (NNI) were calculated. Multivariate logistic regression identified predictors of CSFs. The mean age was 51.7\u2009\u00b1\u200912.3\u00a0years. Most patients (n\u2009=\u20095168) had received PPI therapy, while 837 were on H2RAs and 434 were untreated. CSFs were most frequent among untreated patients (27.9%), followed by H2RA users (18.2%), and were lowest in the PPI group (11.5%) (P\u00a0&amp;lt;\u20090.01 for all comparisons). In the PPI subgroup, multivariate analyses identified older age, Arab ethnicity, hiatal hernia, shorter PPI duration (&amp;lt; 8 weeks), and low-dose PPI therapy as independent predictors of CSFs. The prevalence of upper GI malignancy was low: 0.04% in patients &amp;lt;50\u00a0years (NNI\u2009=\u20092290) and 0.17% in those \u226550\u00a0years (NNI\u2009=\u2009585). The diagnostic yield of gastroscopy in patients with persistent heartburn is modest. CSF detection was more strongly associated with treatment duration and PPI dose, rather than frequency. Given the low yield in younger patients and those adequately treated, clinical strategies should prioritize adherence to optimized therapy and lifestyle measures prior to endoscopy referral.<\/jats:p>\n               <jats:p>Study Highlights \u00a0Gastroesophageal reflux disease is one of the most common gastrointestinal disorders, with heartburn as its hallmark symptom. Despite its frequency, refractory heartburn remains underexplored.In patients with proton pump inhibitor (PPI)\u2013refractory heartburn, gastroscopy detected clinically significant findings (CSFs) in 11.5% of cases. Moreover, Upper GI malignancies were exceedingly rare, with a prevalence of 0.04% in patients under 50\u00a0years and 0.17% in those aged 50 and above, resulting in a high number needed to investigate, highlighting its limited utility in routine evaluation.CSFs were most frequent among untreated patients (27.9%), followed by H2RA users (18.2%), and were lowest in the PPI group (11.5%) (P\u2009&amp;lt;\u20090.01 for all comparisons).Independent predictors of CSFs included older age, hiatal hernia, shorter PPI duration, and low-dose PPI therapy. In contrast, PPI dosing frequency and type were not significantly associated with CSF risk.Differences in PPI utilization and treatment duration between ethnic groups highlight the importance of understanding demographic variations to optimize care for all patients.<\/jats:p>","DOI":"10.1093\/dote\/doaf072","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:43:45Z","timestamp":1756295025000},"source":"Crossref","is-referenced-by-count":0,"title":["Yield of upper endoscopy and predictors of clinically relevant outcomes in patients with proton pump inhibitor\u2013refractory heartburn"],"prefix":"10.1093","volume":"38","author":[{"given":"Fadi Abu","family":"Baker","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center , Hadera ,","place":["Israel"]},{"name":"Bruce Rappaport Faculty of Medicine, Technion \u2013 Israel Institute of Technology , Haifa ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawi","family":"Hazzan","sequence":"additional","affiliation":[{"name":"Liver Clinic, Clalit Health Services , Nof Haglil ,","place":["Israel"]},{"name":"Azrieli Faculty of Medicine, Bar-Ilan University , Safed ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Gal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center , Hadera ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randa","family":"Natour","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center , Hadera ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorin","family":"Nicola","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center , Hadera ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3522-7292","authenticated-orcid":false,"given":"Amir","family":"Farah","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin , Milwaukee, WI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Mari","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Azrieli Faculty of Medicine , Nazareth Hospital EMMS, , Ramat Gan ,","place":["Israel"]},{"name":"Bar Ilan University , Nazareth Hospital EMMS, , Ramat Gan ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"1","key":"2025091916165461300_ref1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12889-023-15272-z","article-title":"Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"23","author":"Li","year":"2023","journal-title":"BMC Public Health"},{"issue":"6","key":"2025091916165461300_ref2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S2468-1253(19)30408-X","article-title":"The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"GBD 2017 Gastro-oesophageal Reflux Disease Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2025091916165461300_ref3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000502796","article-title":"Clinical presentation of gastroesophageal reflux disease: a prospective study on symptom diversity and modification of questionnaire application","volume":"38","author":"Broderick","year":"2020","journal-title":"Dig Dis"},{"issue":"1","key":"2025091916165461300_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathophys.2017.09.001","article-title":"Gastroesophageal reflux disease: a clinical overview for primary care physicians","volume":"25","author":"Pandit","year":"2018","journal-title":"Pathophysiology."},{"issue":"12","key":"2025091916165461300_ref5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-013-0101-8","article-title":"Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment","volume":"73","author":"Hom","year":"2013","journal-title":"Drugs."},{"issue":"6","key":"2025091916165461300_ref6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.gie.2015.02.021","article-title":"The role of endoscopy in the management of GERD","volume":"81","author":"ASGE Standards of Practice Committee","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2025091916165461300_ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5009\/gnl16615","article-title":"Current trends in the Management of Gastroesophageal Reflux Disease","volume":"12","author":"Sandhu","year":"2018","journal-title":"Gut Liver"},{"key":"2025091916165461300_ref8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0884533608318106","article-title":"Diet and lifestyle modifications in the management of gastroesophageal reflux disease","volume":"23","author":"Vemulapalli","year":"2008","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"2025091916165461300_ref9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gtc.2013.12.003","article-title":"Role of endoscopy in GERD","volume":"43","author":"Sharma","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"2025091916165461300_ref10","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/deo2.86","article-title":"The role of endoscopy in the management of gastroesophageal reflux disease","volume":"2","author":"Kuribayashi","year":"2021","journal-title":"DEN Open"},{"issue":"Suppl 1","key":"2025091916165461300_ref11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000151255","article-title":"A critical assessment of the current status of non-erosive reflux disease","volume":"78","author":"Armstrong","year":"2008","journal-title":"Digestion."},{"issue":"6","key":"2025091916165461300_ref12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.5946\/ce.2023.182","article-title":"Role of endoscopy in gastroesophageal reflux disease","volume":"56","author":"Simadibrata","year":"2023","journal-title":"Clin Endosc"},{"issue":"1","key":"2025091916165461300_ref13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcna.2018.08.002","article-title":"Proton pump inhibitor-refractory gastroesophageal reflux disease","volume":"103","author":"Yadlapati","year":"2019","journal-title":"Med Clin North Am"},{"issue":"5","key":"2025091916165461300_ref14","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"2013","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2025091916165461300_ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and Management of Gastroesophageal Reflux Disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2025091916165461300_ref16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1053\/j.gastro.2004.03.077","article-title":"Gastroesophageal reflux among different racial groups in the United States","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"2025091916165461300_ref17","doi-asserted-by":"crossref","first-page":"dox154","DOI":"10.1093\/dote\/dox154","article-title":"Systematic review: methodological flaws in racial\/ethnic reporting for gastroesophageal reflux disease. Diseases of the esophagus: official journal of the international society for","volume":"31","author":"Craven","year":"2018","journal-title":"Dis Esophagus"},{"issue":"2","key":"2025091916165461300_ref18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut"},{"key":"2025091916165461300_ref19","doi-asserted-by":"crossref","first-page":"21501327211046736","DOI":"10.1177\/21501327211046736","article-title":"The medical Management of Gastroesophageal Reflux Disease: a narrative review","volume":"12","author":"Kr\u00f6ner","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"12","key":"2025091916165461300_ref20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4253\/wjge.v2.i12.388","article-title":"Gastroesophageal reflux disease: important considerations for the older patients","volume":"2","author":"Chait","year":"2010","journal-title":"World J Gastrointest Endosc"},{"key":"2025091916165461300_ref21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2025091916165461300_ref22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable use of proton pump inhibitors based on relative potency","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/5\/doaf072\/64273409\/doaf072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/5\/doaf072\/64273409\/doaf072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:16:59Z","timestamp":1758313019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doaf072\/8254287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doaf072","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"type":"print","value":"1120-8694"},{"type":"electronic","value":"1442-2050"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,1]]},"article-number":"doaf072"}}